Parkinson's Disease in Women and Men: What's the Difference?

Research output: Contribution to journalArticle

Abstract

Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progression of the disease. Moreover, motor and nonmotor symptoms, response to treatments and disease risk factors differ between women and men. Altogether, sex-related differences in PD support the idea that disease development might involve distinct pathogenic mechanisms (or the same mechanism but in a different way) in male and female patients. This review summarizes the most recent knowledge concerning differences between women and men in PD clinical features, risk factors, response to treatments and mechanisms underlying the disease pathophysiology. Unraveling how the pathology differently affect the two sexes might allow the development of tailored interventions and the design of innovative programs that meet the distinct needs of men and women, improving patient care.

Original languageEnglish
Pages (from-to)501-515
Number of pages14
JournalJournal of Parkinson's Disease
Volume9
Issue number3
DOIs
Publication statusPublished - Aug 4 2019

Fingerprint

Parkinson Disease
Sex Characteristics
Disease Progression
Patient Care
Pathology
Mortality
Therapeutics

Cite this

Parkinson's Disease in Women and Men : What's the Difference? / Cerri, Silvia; Mus, Liudmila; Blandini, Fabio.

In: Journal of Parkinson's Disease, Vol. 9, No. 3, 04.08.2019, p. 501-515.

Research output: Contribution to journalArticle

@article{59b5fc66cda54369be987e0656c8c68a,
title = "Parkinson's Disease in Women and Men: What's the Difference?",
abstract = "Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progression of the disease. Moreover, motor and nonmotor symptoms, response to treatments and disease risk factors differ between women and men. Altogether, sex-related differences in PD support the idea that disease development might involve distinct pathogenic mechanisms (or the same mechanism but in a different way) in male and female patients. This review summarizes the most recent knowledge concerning differences between women and men in PD clinical features, risk factors, response to treatments and mechanisms underlying the disease pathophysiology. Unraveling how the pathology differently affect the two sexes might allow the development of tailored interventions and the design of innovative programs that meet the distinct needs of men and women, improving patient care.",
author = "Silvia Cerri and Liudmila Mus and Fabio Blandini",
year = "2019",
month = "8",
day = "4",
doi = "10.3233/JPD-191683",
language = "English",
volume = "9",
pages = "501--515",
journal = "Journal of Parkinson's Disease",
issn = "1877-7171",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Parkinson's Disease in Women and Men

T2 - What's the Difference?

AU - Cerri, Silvia

AU - Mus, Liudmila

AU - Blandini, Fabio

PY - 2019/8/4

Y1 - 2019/8/4

N2 - Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progression of the disease. Moreover, motor and nonmotor symptoms, response to treatments and disease risk factors differ between women and men. Altogether, sex-related differences in PD support the idea that disease development might involve distinct pathogenic mechanisms (or the same mechanism but in a different way) in male and female patients. This review summarizes the most recent knowledge concerning differences between women and men in PD clinical features, risk factors, response to treatments and mechanisms underlying the disease pathophysiology. Unraveling how the pathology differently affect the two sexes might allow the development of tailored interventions and the design of innovative programs that meet the distinct needs of men and women, improving patient care.

AB - Increasing evidence points to biological sex as an important factor in the development and phenotypical expression of Parkinson's disease (PD). Risk of developing PD is twice as high in men than women, but women have a higher mortality rate and faster progression of the disease. Moreover, motor and nonmotor symptoms, response to treatments and disease risk factors differ between women and men. Altogether, sex-related differences in PD support the idea that disease development might involve distinct pathogenic mechanisms (or the same mechanism but in a different way) in male and female patients. This review summarizes the most recent knowledge concerning differences between women and men in PD clinical features, risk factors, response to treatments and mechanisms underlying the disease pathophysiology. Unraveling how the pathology differently affect the two sexes might allow the development of tailored interventions and the design of innovative programs that meet the distinct needs of men and women, improving patient care.

U2 - 10.3233/JPD-191683

DO - 10.3233/JPD-191683

M3 - Article

C2 - 31282427

VL - 9

SP - 501

EP - 515

JO - Journal of Parkinson's Disease

JF - Journal of Parkinson's Disease

SN - 1877-7171

IS - 3

ER -